The accumulation of monoclonal chronic lymphocytic leukemia B (B-CLL)
cells may be due to excessive proliferation and longevity. Clinical pr
ogression may thus come from a constitutive but altered expression of
a number of genes that results in extended B-CLL cells life span, incr
eased proliferative capacity and diminished cell death. B-CLL cells ex
press a number of surface markers that characterise the normal B-cells
phenotype. However, B-CLL cells are CD5 positive and most of them als
o express CD6, surface receptors that are present in just a small subs
et of normal B-cells. When exploring CD6 function, we found out that c
ross-linking of CD6 protected B-CLL from anti-IgM-induced apoptosis. C
D6 activation blocked anti-IgM-induced Bar, up-regulation and, by doin
g so, corrected an imbalance in the Bcl-2/Bax ratio that accompanies a
poptosis. Here, we review all surface receptors and cytokines that hav
e been described as participating in the induction or protection of B-
CLL apoptosis together with data on chemosensitivity and gene modulati
on, data on the Fas receptor/Fas ligand system, and the implications o
f all the latter for B-CLL cell survival.